Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Clive Beresford Thompson has worked on the following 3 EPO patent applications which have been published in the last five years:

EP12725349

COMPOSITIONS FOR PERCUTANEOUS ADMINISTRATION OF PHYSIOLOGICALLY ACTIVE AGENTS

IPC classification:
A61K 9/00, A61K 9/70, A61K 47/32
Applicant:
Novartis AG
Agent:
Clive Beresford Thompson, GlaxoSmithKline
Agent:
Florian Bielefeldt, Novartis Consumer Health SA
Status:
GRANT OF PATENT INTENDED
EP14163452

Dispensing head for dispensing a viscous material from a container

IPC classification:
A45D 34/04, B65D 35/36, B65D 47/20, B65D 51/22
Applicant:
Novartis AG
Agent:
Clive Beresford Thompson, GlaxoSmithKline
Status:
APPLICATION REFUSED
EP09801365

MELT EXTRUDED NICOTINE THIN STRIPS

IPC classification:
A61K 9/00, A61K 9/70, A61K 31/465
Applicant:
Novartis AG
Agent:
Clive Beresford Thompson, GlaxoSmithKline
Agent:
Bernd Liphardt, Novartis Consumer Health SA
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature